Cefuroxime + SulbactamThird Party Manufacturing in India

Cefuroxime + Sulbactam works by combining a cell-wall synthesis inhibitor with a beta-lactamase inhibitor. It inhibits bacterial cell wall assembly via cefuroxime while sulbactam permanently binds to and inactivates beta-lactamase enzymes to help the body clear resistant bacterial strains. Unlike plain cephalosporins, it protects the active antibiotic core from enzymatic breakdown by resistant bacteria. Production is monitored closely across our partner networks. It is highly effective and well-tolerated.

Therapeutic Uses

• Gynecological Infections: Prescribed for pelvic inflammatory disease and complex intra-abdominal infections.
• Surgical Prophylaxis: Utilized perioperatively to prevent post-surgical site bacterial contamination.
• Severe Respiratory Infections: Indicated for hospital-acquired respiratory tract infections showing beta-lactamase resistance.

Why Manufacturers Choose Cefuroxime + Sulbactam

This combination molecule is a premier selection for corporate buyers looking to counter growing antimicrobial resistance patterns in clinical settings. Sourcing via Cefuroxime + Sulbactam third party manufacturing in India helps brands establish an advantageous competitive edge over basic formulations. Our production processes fulfill WHO-GMP standards to fulfill international quality parameters. Sourcing under primary CAS 55268-75-2 guarantees authentic chemical validation and reliable shelf-life stability.